Baxter International Inc.

Baxter Healthcare Sa

Baxter Aktiengesellschaft

Immuno Aktiengesellschaft Fur Chemisch-medizinische Produkte

Morphomed Gmbh

Other

Immuno Aktiengesellschaft

C a Casyso Gmbh

C a Casyso Ag

Polymun Scientific Immunbiologische Forschung Gmbh

Liporegena Gmbh

Trauma Care Consult Traumatologische Forschung Gemeinnützige Gesellschaft Mbh

Teuschl, Andreas

Ludwig Boltzmann Gesellschaft

Scott R. Ariagno

Heinz Redl

Johann J Eibl

Zafar Khakpour

Scott R Ariagno

Guenther Schlag

Lillian G Zakarija

Walter Fuerst

Rudolf Kneidinger

Andreas Kellner

Douglas L Looker

Sam L Helgerson

Georg Habison

Jane P Richards

Wolfgang Holnthoner

Elisabeth M Inman

Catalina Wong

Gunther Schlag

Johannes Zipperle

Christoph Schlimp

Alexander Petter-Puchner

Martijn Van Griensven

Andreas Teuschl

Herbert Schochl

Thomas Seelich

Robert Weik

Thomas Hemetsberger

Reiner Spaethe

Gert Kriwetz

Eleni Priglinger

Irmgard Schlag, Legal Representative

Nestor Pridun

Christoph Wurzer

Manuela Simunek

Rene Fortelny

Sylvia Nürnberger

Johann Zehetner

Xiao-Hua Qin

Paul Slezak

Herbert SCHÖCHL

Anthony P Mc Hale

Georg Feichtinger

Nikolitsa Nomikou

Non-enzymatic method and milling device for preparing therapeutic cells from adipose tissue comprising: continuously feeding the adipose tissue to the milling device (); mechanically separating the cells or cell aggregates from adipose tissue moving through the milling device () by means of a multiplicity of blades () of a rotor (), wherein the blades () are arranged in a spaced arrangement with respect to the overall direction of flow and the blades () are moving about an axis of rotation (), wherein the axis of rotation () is provided essentially parallel to said overall direction of flow; continuously withdrawing the processed tissue comprising the separated cells from the milling device ().

Non-enzymatic method and milling device

This disclosure provides a method for measuring coagulation of blood or plasma samples using viscoelastic tests (VET) wherein the measuring is performed in the presence of immobilised endothelial cells.

Method for measuring coagulation of blood samples using viscoelastic tests (VET)

Disclosed is a method for the production of three-dimensional silk products, wherein native silk fibers are formed to a three-dimensional silk product and the silk product formed is subjected to a degumming step wherein a borate buffer is used as degumming agent and wherein the silk product formed is preferably contacted with an aqueous ethanol buffer prior to the degumming step.

Product made of native silk fibres

Disclosed is a method for the production of three-dimensional silk products, wherein a three-dimensional silk product is treated with a silk solvent for a limited period of time so that a partial disintegration of the silk product is obtained whereafter the partially disintegrated silk product is re-stabilized with physical &#x3b2;-sheet induction by a re-stabilizing solution.

Product made of silk

The present invention provides a method of fixating a mesh implant to a tissue of a subject comprising attaching said mesh implant to said tissue, covering said mesh implant by an antiadhesive barrier, wherein said antiadhesive barrier is attached to said mesh implant by a biocompatible adhesive.

Method for the improvement of mesh implant biocompatibility

This disclosure provides a method for measuring coagulation of blood or plasma samples using viscoelastic tests (VET) wherein the measuring is performed in the presence of immobilized endothelial cells.

A laparoscopic tissue sealant spray apparatus and system having a laparoscopic tissue sealant spray assembly combined with a trocar assembly, the tissue sealant spray assembly having an elongate delivery tube. A spray outlet at a distal end of the elongate delivery tube may be rounded or angled. A ring member provided at the distal end of the elongate delivery tube directs a spray cone toward a portion of a target tissue site, and the spray cone may be repositioned to a different portion of the target tissue site by rotation of the elongate delivery tube. The trocar assembly includes a vent opening that connects to a venting valve member that provides a vent path which passively opens upon operation of the tissue sealant spray assembly, avoiding excessive pressure build-up within a body cavity.

Tissue sealing system and apparatus

The present invention relates to recombinant fusion proteins wherein erythropoietin (EPO) is linked via its C-terminus to an Fc fragment, and wherein the recombinant fusion proteins are further carbamoylated at the primary amines of the fusion protein. More specifically the invention relates to carbamoylated EPO-Fc fusion proteins, wherein at least one, preferably two or more, lysine amine residues and/or the N-terminal amino acid of the fusion protein are carbamoylated. The carbamoylated EPO-Fc fusion proteins of the present invention having a reduced hematopoietic activity whereas the tissue regenerative activity, i.e. the nerve cell regenerative activity remains unaltered or is even enhanced as compared to unmodified EPO-Fc fusion proteins. The invention further relates to a process for the manufacture of such fusion proteins and to pharmaceutical compositions containing them, as well as to the use of such fusion proteins and pharmaceutical compositions for medical therapy.

Carbamoylated EPO-Fc fusion proteins

A tissue sealant applicator system includes a tissue sealant applicator having an elongate body forming a bore containing a tissue sealant component, a piston, and a spray adaptor in fluid communication with the bore and forming a gas flow path. The system also includes a control unit adapted to be connected to a gas source, and a first gas passageway connecting the gas flow path and the control unit. The applicator includes an actuating member cooperatively associated with the piston to eject the tissue sealant from the bore upon user actuation. The control unit is adapted to supply gas from the gas source to the first gas passageway essentially simultaneously with user actuation of the actuating member, and to permit the supply of gas to the spray adaptor from the gas source to continue to flow for a predetermined time delay after the user stops actuating the actuating member.

Tissue sealant applicator system

The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.

Fibrinogen-based tissue adhesive containing an elastase inhibitor

An applicator includes a bore for containing a sealant component, a piston moveably positioned in the bore, a plunger member connected to the piston with a distal end disposed within the bore and a proximal end depending from the bore, a distal outlet communicating with the bore and connectable to a gas source, and an actuating member carried by the proximal end of the plunger member to move with the plunger member as the plunger member moves along the bore. The applicator may be used in a system with a gas source connected to the distal outlet, and a control unit connected to the actuating member and the gas source, the control unit adapted to supply gas to the distal outlet from the gas source essentially simultaneous with a force applied to the actuating member.

Hand triggered tissue sealant spray apparatus and system

The present invention is generally directed to various structures for applying a sealant to a work surface. In one aspect of the invention, a sealant applicator assembly is provided for use with an apparatus of the type having an elongated body defining an interior bore and having a piston movably positioned in the bore and a pusher member operatively associated with the piston. The assembly comprises a spray adaptor adapted to communicate with the bore of the body and defining a distal outlet. A first gas passageway is cooperatively associated with the distal outlet and configured to direct gas to create a spray discharge of the sealant. An actuating member is adapted to be cooperative associated with a pusher member to eject sealant through the distal outlet and is operative to simultaneously actuate a supply of gas to the first gas passageway for creating a spray discharge of sealant.

Growing community of inventors

Vienna, Austria

Heinz Redl